Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,760,080 papers from all fields of science
Search
Sign In
Create Free Account
carvedilol phosphate
The phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule
24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule [Coreg]
Adrenergic alpha-Antagonists [MoA]
Angina Pectoris
Expand
Narrower (1)
Coreg
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Smart karaya-locust bean gum hydrogel particles for the treatment of hypertension: Optimization by factorial design and pre-clinical evaluation.
B. Laha
,
Rimpa Goswami
,
S. Maiti
,
K. Sen
Carbohydrate polymers
2019
Corpus ID: 73434726
2017
2017
Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial
M. Guglin
,
P. Munster
,
A. Fink
,
J. Krischer
American heart journal
2017
Corpus ID: 676160
2014
2014
Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate
Venkata Srikanth Meka
,
Vanitha A P Hong Wee Liang
,
Senthil Rajan Dharmalingham
,
R. Sheshala
,
A. Gorajana
Acta pharmaceutica
2014
Corpus ID: 6842129
Abstract The objective of the study was to enhance the solubility of carvedilol phosphate and to formulate it into non…
Expand
Highly Cited
2012
Highly Cited
2012
Adherence and dosing frequency of common medications for cardiovascular patients.
J. Bae
,
P. Dobesh
,
+4 authors
Molly E. Tomlin
The American journal of managed care
2012
Corpus ID: 21042869
OBJECTIVES To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications…
Expand
2012
2012
Quantifying the Structural Dynamics of Pharmaceuticals in the Glassy State.
Z. Wojnarowska
,
C. M. Roland
,
K. Kolodziejczyk
,
A. Swiety-Pospiech
,
K. Grzybowska
,
M. Paluch
The journal of physical chemistry letters
2012
Corpus ID: 528835
Structural dynamics in the glassy state of two protic ionic liquids, carvedilol phosphate and procaine hydrochloride, were…
Expand
2011
2011
Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design.
A. Avachat
,
K. Patel
,
M. S. Rokade
,
R. R. Dash
PDA journal of pharmaceutical science and…
2011
Corpus ID: 34307032
UNLABELLED A 3(2) full factorial design was employed for the formulation and characterization of an expandable, gastroretentive…
Expand
2011
2011
Effective in‐vivo utilization of lipid‐based nanoparticles as drug carrier for carvedilol phosphate
S. Chakraborty
,
D. Shukla
,
P. R. Vuddanda
,
B. Mishra
,
Sanjay Singh
The Journal of pharmacy and pharmacology
2011
Corpus ID: 504457
Objectives Lipid nanoparticles as carrier for oral drug administration improve gastrointestinal solubility of poorly soluble…
Expand
2010
2010
Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles.
S. Chakraborty
,
D. Shukla
,
P. R. Vuddanda
,
B. Mishra
,
Sanjay Singh
Colloids and surfaces. B, Biointerfaces
2010
Corpus ID: 24725944
Highly Cited
2009
Highly Cited
2009
Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH.
S. Chakraborty
,
D. Shukla
,
Achint Jain
,
B. Mishra
,
Sanjay Singh
Journal of colloid and interface science
2009
Corpus ID: 24020260
2009
2009
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily…
J. Udelson
,
S. Pressler
,
+4 authors
P. Hauptman
Journal of cardiac failure
2009
Corpus ID: 5809030
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE